Please ensure Javascript is enabled for purposes of website accessibility
Small-Cap Confidential
Undiscovered stocks that can make you rich

January 4, 2022

Two days into 2022 and we’re seeing another round of selling in growth names, especially software, fintech, medical devices and e-commerce. Many names are retesting their November and/or December lows. We have seen a few names crack their 200-day lines, while a few others have begun to rebound intra-day.

Two days into 2022 and we’re seeing another round of selling in growth names, especially software, fintech, medical devices and e-commerce. Many names are retesting their November and/or December lows. We have seen a few names crack their 200-day lines, while a few others have begun to rebound intra-day.

There’s very little stock-specific news driving this action. Headlines suggest a jump in the 10-year yield is the culprit, which is plausible. The current yield of 1.665% is at the top end of the last three months’ trading range. Previous runs to around here have brought about some selling in growthy names before.

Meanwhile, we also see a host of larger, slower-growth large-cap names continuing to do very well. Examples include IBM (IBM), Ford (F) and Visa (V) and Mastercard (MA), just to flag a few.

My inclination is to think this is a retest of recent lows for many stocks. But nothing is off the table. We will likely see how the afternoon closes and tomorrow morning begins before making any major decisions.